BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9752976)

  • 1. Immunoblotting analysis of schwannomin/merlin in human schwannomas.
    Harwalkar JA; Lee JH; Hughes G; Kinney SE; Golubić M
    Am J Otol; 1998 Sep; 19(5):654-9. PubMed ID: 9752976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of schwannomin/merlin in human sporadic meningiomas.
    Lee JH; Sundaram V; Stein DJ; Kinney SE; Stacey DW; Golubić M
    Neurosurgery; 1997 Mar; 40(3):578-87. PubMed ID: 9055299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).
    Halum SL; Erbe CB; Friedland DR; Wackym PA
    Otolaryngol Head Neck Surg; 2003 Mar; 128(3):364-71. PubMed ID: 12646839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
    Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
    Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.
    Huynh DP; Pulst SM
    Oncogene; 1996 Jul; 13(1):73-84. PubMed ID: 8700556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Ki-67 antigen and vascular endothelial growth factor in sporadic and neurofibromatosis type 2-associated schwannomas.
    Saito K; Kato M; Susaki N; Nagatani T; Nagasaka T; Yoshida J
    Clin Neuropathol; 2003; 22(1):30-4. PubMed ID: 12617191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
    Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
    Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
    Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
    Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation.
    Fraenzer JT; Pan H; Minimo L; Smith GM; Knauer D; Hung G
    Int J Oncol; 2003 Dec; 23(6):1493-500. PubMed ID: 14612918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new tumor suppressor gene responsible for type 2 neurofibromatosis is inactivated in neurinoma and meningioma].
    Sanson M
    Rev Neurol (Paris); 1996 Jan; 152(1):1-10. PubMed ID: 8729390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas.
    Lallemand D; Manent J; Couvelard A; Watilliaux A; Siena M; Chareyre F; Lampin A; Niwa-Kawakita M; Kalamarides M; Giovannini M
    Oncogene; 2009 Feb; 28(6):854-65. PubMed ID: 19029950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
    Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Audiologic presentation of vestibular schwannomas in neurofibromatosis type 2.
    Lalwani AK; Abaza MM; Makariou EV; Armstrong M
    Am J Otol; 1998 May; 19(3):352-7. PubMed ID: 9596188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression between human schwannoma and control Schwann cells.
    Hanemann CO; Bartelt-Kirbach B; Diebold R; Kämpchen K; Langmesser S; Utermark T
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):605-14. PubMed ID: 17083475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
    Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ
    J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).
    Scoles DR; Yong WH; Qin Y; Wawrowsky K; Pulst SM
    Hum Mol Genet; 2006 Apr; 15(7):1059-70. PubMed ID: 16497727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
    Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
    Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
    Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
    Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development.
    Huynh DP; Tran TM; Nechiporuk T; Pulst SM
    Cell Growth Differ; 1996 Nov; 7(11):1551-61. PubMed ID: 8930405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.